GLP-1 Therapy in 2026: Clinical Expansion, Coverage Changes, and the Evolving Role of Utilization Management
GLP-1 Therapy in 2026: Clinical Expansion, Coverage Changes, and the Evolving Role of Utilization Management
A thought-leadership discussion exploring the rapid clinical expansion of GLP-1 receptor agonist therapies, the shifting coverage landscape across Medicare, Medicaid, and commercial payers, and the growing role of pharmacist-led utilization management in supporting appropriate access and consistent evidence-based decision-making. Our experts share…